Abstract:Schizophrenia is a devastating disease with a prevalence of 1% in populations around the world. Current diagnostic techniques of schizophrenia and high-risk population are based on subjective psychiatric interviews. Early diagnosis and intervention can mitigate progression and improve treatment outcomes. However, the lack of biomarkers that support objective examinations has been a long-term bottleneck in clinical diagnosis and assessment of schizophrenia and its high-risk state. In the present study, resting-state 128-channel electroencephalogram (EEG) data were acquired from 65 participants, including clinically-stable individuals with first-episode schizophrenia (FESZ), individuals at ultra-high-risk (UHR) and high-risk (HR), and healthy controls (HC). Microstate analysis was used to assess the dynamics of functional networks in these participants. Three features were extracted for each class of microstate (A, B, C, D, E, F): duration, occurrence and time coverage. Furthermore, clinical examinations and cognitive tests were performed. Behavioral results showed poorer performances in the participants as the disease progressed. Moreover, microstate features computed from resting-state EEG microstates (especially microstate class D) were capable of distinguishing the four groups of individuals. Combined biomarkers including clinical examinations, cognitive tests and EEG microstate parameters were identified as a potential effective diagnostic tool, achieving the highest classification performance using the random forest model compared with the support vector machine (SVM) and long short term memory (LSTM) networks, with an average classification of 92%, mean sensitivity of 91.8%, and specificity of 90.8% among the four groups, which were much higher than that only using behavioral features. The results demonstrate that microstate-based indicators together with behavioral results may act as biomarkers for early diagnosis and prediction of at-risk individuals of schizophrenia. Furthermore, our findings illustrate the potential use of resting-state EEG in clinical screening, classification and quantitative evaluation of patients with neurodevelopmental disorders.

P182. Diagnostic Classification of Schizophrenia and Bipolar Disorders Using Machine Learning on Resting-State EEG

DISTINGUISHING BIPOLAR DEPRESSION FROM MAJOR DEPRESSIVE DISORDER USING FNIRS AND DEEP NEURAL NETWORK

[Resting-State Electroencephalogram Classification of Patients with Schizophrenia or Depression].

Schizophrenia classification using machine learning on resting state EEG signal

Assisting Schizophrenia Diagnosis Using Clinical Electroencephalography and Interpretable Graph Neural Networks: a Real-World and Cross-Site Study

Diagnostic deep learning algorithms that use resting EEG to distinguish major depressive disorder, bipolar disorder, and schizophrenia from each other and from healthy volunteers

A machine learning approach for differentiating bipolar disorder type II and borderline personality disorder using electroencephalography and cognitive abnormalities

Schizophrenia diagnosis based on diverse epoch size resting-state EEG using machine learning

A Data Driven Approach for Resting-state EEG signal Classification of Schizophrenia with Control Participants using Random Matrix Theory

Identification of Depression Subtypes Based on EEG and Machine Learning.

Identification of Depression Subtypes Based on EEG and Machine Learning

Classification of Schizophrenia by Combination of Brain Effective and Functional Connectivity

Machine learning with electroencephalography features for precise diagnosis of depression subtypes

Automatic identification of schizophrenia based on EEG signals using dynamic functional connectivity analysis and 3D convolutional neural network

Automated Rest EEG-Based Diagnosis of Depression and Schizophrenia Using a Deep Convolutional Neural Network

Distinguishing Schizophrenia and Bipolar Disorder Through a Multiclass Classification Model Based on Multimodal Neuroimaging Data.

Machine Learning Algorithm Performance Evaluation in Structural Magnetic Resonance Imaging-Based Classification of Pediatric Bipolar Disorders Type I Patients.

Multi-scale Convolutional Recurrent Neural Network for Psychiatric Disorder Identification in Resting-State EEG

Individualized identification of first-episode bipolar disorder using machine learning and cognitive tests

A convolutional neural network-based diagnostic method using resting-state electroencephalograph signals for major depressive and bipolar disorders

Biomarkers for Prediction of Schizophrenia: Insights From Resting-State EEG Microstates